Fig. 7.
Fig. 7. Hematopoietic cells from some STI571-treated mice express increased levels of Bcr/Abl protein. / Protein lysates from blood and BM cells from either STI571-treated (left, lanes 1-4) or STI571-untreated (right, lanes 5-8) mice were analyzed by anti-Abl immunoblot. As a control, lysates from wild type (WT) Ba/F3 or a population of growth factor–independent Ba/F3 cells expressing P210BCR/ABL (B/A) are shown at left. The position of Bcr/Abl and endogenous c-Abl are shown at the arrows.

Hematopoietic cells from some STI571-treated mice express increased levels of Bcr/Abl protein.

Protein lysates from blood and BM cells from either STI571-treated (left, lanes 1-4) or STI571-untreated (right, lanes 5-8) mice were analyzed by anti-Abl immunoblot. As a control, lysates from wild type (WT) Ba/F3 or a population of growth factor–independent Ba/F3 cells expressing P210BCR/ABL (B/A) are shown at left. The position of Bcr/Abl and endogenous c-Abl are shown at the arrows.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal